Live Breaking News & Updates on Commercialization Academy

Stay updated with breaking news from Commercialization academy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bayer extends research agreement with Hopkins through 2024


Bayer extends research agreement with Hopkins through 2024
The pharmaceuticals and life sciences company will continue its partnership with Johns Hopkins to provide funding to researchers in the Wilmer Eye Institute
Credit: Wikimedia Commons
May 6, 2021
The Johns Hopkins University and Bayer AG have extended their strategic research alliance in ophthalmology through the end of 2024. The agreement will provide multimillion-dollar funding for researchers at the Johns Hopkins Wilmer Eye Institute to pursue treatments for a variety of eye diseases and ailments while benefitting from the expertise of Bayer scientists about potential drug candidates.
A drug candidate from one of the collaboration s programs has advanced to a phase II clinical trial and another program is licensed to a startup company. Researchers on both sides hope to translate the joint research into improved vision by moving innovative treatments from labs to patients eyes. ....

Janice Lin , Neilm Bressler , Bydanny Jacobspublished , Peterj Mcdonnell , Johns Hopkins , Johns Hopkins University , Bayer Ag , School Of Medicine , Johns Hopkins Technology Ventures , Johns Hopkins University School Of Medicine , Wilmer Eye Institute , Commercialization Academy , Johns Hopkins Wilmer Eye Institute , Association For Research , Wilmer Eye , Johns Hopkins Technology , Laura Ensign , Johns Hopkins University School , ஜானிஸ் லின் , ஜான்ஸ் ஹாப்கின்ஸ் , ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் , பள்ளி ஆஃப் மருந்து , ஜான்ஸ் ஹாப்கின்ஸ் தொழில்நுட்பம் முயற்சிகள் , ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , வில்மர் கண் நிறுவனம் , வணிகமயமாக்கல் கலைக்கழகம் ,